| TRADING CENTER |
| Banks Flexing Their M&A Muscles ($) - at TheStreet.com | |
| FACTBOX-Winners, losers in U.S. Senate health bill - Reuters | |
| US Cosmetic Medical Market Faces New Challenge In Senate Bill - Dow Jones | |
| Earnings highlights: Aetna, Allergan, E*Trade, Goodyear, RadioShack, SAP, Visa ... - Bloggingstocks.com | |
| Pharma earnings recap: Mylan, Allergan, Novo-Nordisk - Bloggingstocks.com | |
| Pharma earns: Glaxo, AstraZeneca lifted by swine flu vaccine sales - DailyFinance | |
| WRAPUP 2-Avon sales miss on weak North America, Arden beats - Reuters | |
| Allergan profit rises as Botox rebounds - Reuters | |
| Allergan profit rises, Botox rebounds - Reuters | |
| Allergan Reports Third Quarter 2009 Operating Results - Business Wire | |
Implant market still strong - CNNMoney.com |
| Last trade | Change/%change | P/E ratio | ||
|---|---|---|---|---|
| JNJ | Johnson & Johnson | 63.30 | 0.00 / 0.00% | 13.82 |
| PFE | Pfizer Inc | 18.59 | 0.00 / 0.00% | 15.62 |
| NVS | Novartis AG | 55.85 | 0.00 / 0.00% | 15.69 |
| 2008 Revenue: | $4.4 B | Headquarters: Irvine, CA |
| Employees: | 8,740 | CEO: David E.I. Pyott |
| Net Income: | $578.6 M | Industry: Pharmaceuticals |
| Market Cap: | $18.0 B | Website: www.allergan.com |
| Symbol | Price | Change/%Change | Prev. close | High | Low | Last Update | More Info |
|---|---|---|---|---|---|---|---|
| AGN | 59.33 | 0.00 / 0.00% | 59.33 | 0.00 | 0.00 | Profile Chart News |